SoMex Research & Health
Pvt. Ltd.
+91-141-2504996           
banner11 banner22 banner33 banner44

News & Events


Phase I Trial Managed by SoMex Research & Health Published in ASCO 2012

(25-May-2012)
A phase I study of selective cyclin dependent kinase inhibitor P1446A-05 administered on an intermittent schedule in patients with advanced refractory tumors published in ASCO 2012 (PI Dr. Naresh Somani at Bhagwan Mahaveer Cancer Hospital and Research Center, Jaipur.



Other News